T. Rowe Price Associates’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-34,451
| Closed | -$210K | – | 3096 |
|
|
2021
Q3 | $210K | Buy |
34,451
+15,393
| +81% | +$93.8K | ﹤0.01% | 2701 |
|
|
2021
Q2 | $157K | Buy |
19,058
+507
| +3% | +$4.18K | ﹤0.01% | 2769 |
|
|
2021
Q1 | $166K | Buy |
+18,551
| New | +$166K | ﹤0.01% | 2725 |
|
|
2020
Q4 | – | Sell |
-16,100
| Closed | -$168K | – | 2738 |
|
|
2020
Q3 | $168K | Buy |
16,100
+687
| +4% | +$7.17K | ﹤0.01% | 2453 |
|
|
2020
Q2 | $203K | Buy |
15,413
+211
| +1% | +$2.78K | ﹤0.01% | 2350 |
|
|
2020
Q1 | $120K | Buy |
+15,202
| New | +$120K | ﹤0.01% | 2393 |
|
|
2018
Q4 | – | Sell |
-15,087
| Closed | -$282K | – | 2594 |
|
|
2018
Q3 | $282K | Buy |
15,087
+3,703
| +33% | +$69.2K | ﹤0.01% | 2363 |
|
|
2018
Q2 | $294K | Buy |
11,384
+36
| +0.3% | +$930 | ﹤0.01% | 2343 |
|
|
2018
Q1 | $254K | Buy |
11,348
+74
| +0.7% | +$1.66K | ﹤0.01% | 2334 |
|
|
2017
Q4 | $282K | Buy |
+11,274
| New | +$282K | ﹤0.01% | 2286 |
|